219 related articles for article (PubMed ID: 23608200)
41. Sucupira Oil-Loaded Nanostructured Lipid Carriers (NLC): Lipid Screening, Factorial Design, Release Profile, and Cytotoxicity.
Vieira R; Severino P; Nalone LA; Souto SB; Silva AM; Lucarini M; Durazzo A; Santini A; Souto EB
Molecules; 2020 Feb; 25(3):. PubMed ID: 32041134
[TBL] [Abstract][Full Text] [Related]
42. Preparation and characteristics of monostearin nanostructured lipid carriers.
Hu FQ; Jiang SP; Du YZ; Yuan H; Ye YQ; Zeng S
Int J Pharm; 2006 May; 314(1):83-9. PubMed ID: 16563671
[TBL] [Abstract][Full Text] [Related]
43. Formation of a physical stable delivery system by simply autoclaving nanostructured lipid carriers (NLC).
Pardeike J; Weber S; Matsko N; Zimmer A
Int J Pharm; 2012 Dec; 439(1-2):22-7. PubMed ID: 22989983
[TBL] [Abstract][Full Text] [Related]
44. Construction and in vitro/in vivo evaluation of 17-allylamino-17-demethoxygeldanamycin (17AAG)-loaded PEGylated nanostructured lipid carriers.
Wang Z; Wang J; Yang S; Hou S
Drug Dev Ind Pharm; 2016 Jan; 42(1):91-98. PubMed ID: 25853294
[TBL] [Abstract][Full Text] [Related]
45. Development of artemether-loaded nanostructured lipid carrier (NLC) formulation for topical application.
Nnamani PO; Hansen S; Windbergs M; Lehr CM
Int J Pharm; 2014 Dec; 477(1-2):208-17. PubMed ID: 25290810
[TBL] [Abstract][Full Text] [Related]
46. Tamoxifen-loaded nanostructured lipid carrier as a drug delivery system: characterization, stability assessment and cytotoxicity.
How CW; Rasedee A; Manickam S; Rosli R
Colloids Surf B Biointerfaces; 2013 Dec; 112():393-9. PubMed ID: 24036474
[TBL] [Abstract][Full Text] [Related]
47. Miconazole-loaded nanostructured lipid carriers (NLC) for local delivery to the oral mucosa: improving antifungal activity.
Mendes AI; Silva AC; Catita JA; Cerqueira F; Gabriel C; Lopes CM
Colloids Surf B Biointerfaces; 2013 Nov; 111():755-63. PubMed ID: 23954816
[TBL] [Abstract][Full Text] [Related]
48. Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: comparative analysis of characteristics, pharmacokinetics and tissue uptake.
Tiwari R; Pathak K
Int J Pharm; 2011 Aug; 415(1-2):232-43. PubMed ID: 21640809
[TBL] [Abstract][Full Text] [Related]
49. Development of a new delivery system consisting in "drug--in cyclodextrin--in nanostructured lipid carriers" for ketoprofen topical delivery.
Cirri M; Bragagni M; Mennini N; Mura P
Eur J Pharm Biopharm; 2012 Jan; 80(1):46-53. PubMed ID: 21839833
[TBL] [Abstract][Full Text] [Related]
50. Docosahexaenoic acid loaded lipid nanoparticles with bactericidal activity against Helicobacter pylori.
Seabra CL; Nunes C; Gomez-Lazaro M; Correia M; Machado JC; Gonçalves IC; Reis CA; Reis S; Martins MCL
Int J Pharm; 2017 Mar; 519(1-2):128-137. PubMed ID: 28088639
[TBL] [Abstract][Full Text] [Related]
51. Nanostructured lipid carriers enhance the bioavailability and brain cancer inhibitory efficacy of curcumin both in vitro and in vivo.
Chen Y; Pan L; Jiang M; Li D; Jin L
Drug Deliv; 2016 May; 23(4):1383-92. PubMed ID: 26066035
[TBL] [Abstract][Full Text] [Related]
52. Physicochemical characterization, photo-stability and cytotoxicity of coenzyme Q10-loading nanostructured lipid carrier.
Wang J; Wang H; Zhou X; Tang Z; Liu G; Liu G; Xia Q
J Nanosci Nanotechnol; 2012 Mar; 12(3):2136-48. PubMed ID: 22755031
[TBL] [Abstract][Full Text] [Related]
53. Preparation, characterization and biocompatibility studies of thermoresponsive eyedrops based on the combination of nanostructured lipid carriers (NLC) and the polymer Pluronic F-127 for controlled delivery of ibuprofen.
Almeida H; Lobão P; Frigerio C; Fonseca J; Silva R; Sousa Lobo JM; Amaral MH
Pharm Dev Technol; 2017 May; 22(3):336-349. PubMed ID: 28240141
[TBL] [Abstract][Full Text] [Related]
54. Investigation of the factors influencing the incorporation of clotrimazole in SLN and NLC prepared by hot high-pressure homogenization.
Souto EB; Müller RH
J Microencapsul; 2006 Jun; 23(4):377-88. PubMed ID: 16854814
[TBL] [Abstract][Full Text] [Related]
55. Bupivacaine (S75:R25) Loaded in Nanostructured Lipid Carriers: Factorial Design, HPLC Quantification Method and Physicochemical Stability Study.
Da Silva GHR; de Morais Ribeiro LN; Guilherme VA; de Castro SR; Breitkreitz MC; de Paula E
Curr Drug Deliv; 2018; 15(3):388-396. PubMed ID: 28745230
[TBL] [Abstract][Full Text] [Related]
56. Nanostructured lipid carriers (NLC) on the basis of Siberian pine (Pinus sibirica) seed oil.
Averina ES; Seewald G; Müller RH; Radnaeva LD; Popov DV
Pharmazie; 2010 Jan; 65(1):25-31. PubMed ID: 20187575
[TBL] [Abstract][Full Text] [Related]
57. Nanostructured lipid carriers for parenteral delivery of silybin: Biodistribution and pharmacokinetic studies.
Jia L; Zhang D; Li Z; Duan C; Wang Y; Feng F; Wang F; Liu Y; Zhang Q
Colloids Surf B Biointerfaces; 2010 Oct; 80(2):213-8. PubMed ID: 20621458
[TBL] [Abstract][Full Text] [Related]
58. Nanostructured lipid carriers constituted from high-density lipoprotein components for delivery of a lipophilic cardiovascular drug.
Zhang WL; Gu X; Bai H; Yang RH; Dong CD; Liu JP
Int J Pharm; 2010 May; 391(1-2):313-21. PubMed ID: 20214958
[TBL] [Abstract][Full Text] [Related]
59. Development of an itraconazole-loaded nanostructured lipid carrier (NLC) formulation for pulmonary application.
Pardeike J; Weber S; Haber T; Wagner J; Zarfl HP; Plank H; Zimmer A
Int J Pharm; 2011 Oct; 419(1-2):329-38. PubMed ID: 21839157
[TBL] [Abstract][Full Text] [Related]
60. Characterization and cytotoxicity of nanostructured lipid carriers formulated with olive oil, hydrogenated palm oil, and polysorbate 80.
How CW; Rasedee A; Abbasalipourkabir R
IEEE Trans Nanobioscience; 2013 Jun; 12(2):72-8. PubMed ID: 23268387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
